Multicenter, double-blind, sham endoscopy-controlled, randomized trial evaluating the efficacy of antireflux mucosal ablation for the treatment of gastroesophageal reflux disease
Por:
de Santiago, ER, Sánchez-Vegazo, CT, Albéniz, E, Arévalo, FE, Gamboa, AA, Castel, I, Anta, JA, Marín-Gabriel, JC, Redondo, PD, Rodríguez, HN, De Tejada, AH, Martínez, IE, Pons, FR, Naves, JE, Uchima, H, Marín, I, Alcorta, JMD, Corte, DP, Pallarés, PD, Enciso, IP, Suarez, CG, Lorenzo-Zúñiga, V, Nogales, O, Muriel, A, Albillos, A, García, BP, Carbonell, SP, Sánchez, AM, Ganuza, M, Reina, AIR, Sanz, MD, De Frutos, D, Garcia, JS, Matallana, V, Relea, L, Priego, LB, Muñiz, MP, Bellver, VO, Lledó, JG, Hernández, JA, Segura, AM, Zamora, J, Neves, JAC and Sequeiros, EV
Publicada:
10 feb 2026
Ahead of Print:
1 feb 2026
Resumen:
Background Antireflux mucosal ablation (ARMA) is a novel endoscopic technique for gastroesophageal reflux disease (GERD) but has only been assessed in noncontrolled studies. The objective of this randomized controlled study was to evaluate its efficacy in patients with proton pump inhibitor (PPI)-responsive GERD. Methods We conducted a double-blind, sham endoscopy-controlled, randomized trial across 12 Spanish hospitals. Adults with PPI-responsive GERD and abnormal esophageal acid exposure time (AET > 6 %) were randomly assigned (1:1) to receive ARMA or sham endoscopy. The primary outcome was clinical success at 12 months, defined as a >= 50 % reduction in the GERD-Health-Related Quality of Life score. Inability to discontinue PPIs to allow symptom assessment was considered treatment failure. Secondary outcomes included PPI discontinuation, AET, manometric parameters, mucosal healing, and adverse events. Results Of 186 patients screened, 60 were included (ARMA 31; sham 29). At 12 months, clinical success was achieved in 16 patients (51.6 %) in the ARMA group and in 11 (37.9 %) in the sham group (P = 0.29; risk ratio 1.36, 95 %CI 0.76 to 2.42). No significant differences were observed in PPI discontinuation, AET, manometric findings, or mucosal healing. Postprocedural pain (27.3 % vs. 3.3 %) and dysphagia (45.5 % vs. 10.0 %) occurred more frequently in the ARMA group. No severe adverse events were recorded. Conclusions ARMA was not superior to sham endoscopy in improving GERD-related quality of life at 12 months in patients with PPI-responsive GERD, and was associated with a higher incidence of adverse events. These findings do not support its implementation in routine clinical practice.
Filiaciones:
de Santiago, ER:
Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain
Sánchez-Vegazo, CT:
Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Univ Alcala, Dept Med, Madrid, Spain
Albéniz, E:
Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain
Arévalo, FE:
Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain
Gamboa, AA:
Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain
Castel, I:
Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain
Anta, JA:
Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain
Marín-Gabriel, JC:
Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain
Redondo, PD:
Hosp Rio Hortega, Dept Gastroenterol, Valladolid, Spain
Rodríguez, HN:
Hosp Rio Hortega, Dept Gastroenterol, Valladolid, Spain
De Tejada, AH:
Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain
Martínez, IE:
Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain
Pons, FR:
Hosp del Mar Res Inst, Gastroenterol Dept, Barcelona, Spain
Naves, JE:
Hosp del Mar Res Inst, Gastroenterol Dept, Barcelona, Spain
:
Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain
Hosp Univ Germans Trias i Pujol, Dept Gastroenterol, Endoscopy Unit, Barcelona, Spain
:
Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain
Alcorta, JMD:
Hosp San Agustin, Dept Gastroenterol, Aviles, Spain
Corte, DP:
Hosp San Agustin, Dept Gastroenterol, Aviles, Spain
Pallarés, PD:
Hosp Univ La Paz, Gastroenterol Dept, Madrid, Spain
Enciso, IP:
Hosp Univ La Paz, Gastroenterol Dept, Madrid, Spain
Suarez, CG:
Hosp Cabuenes, Gastroenterol Dept, Gijon, Spain
Lorenzo-Zúñiga, V:
Hosp Univ & Politecn La Fe, Dept Gastroenterol & Hepatol, Gastrointestinal Endoscopy Unit, Inst Invest Sanitaria La Fe, Valencia, Spain
Nogales, O:
Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid, Spain
Muriel, A:
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Univ Alcala, Dept Med, Madrid, Spain
Hosp Ramon & Cajal, Clin Biostat Unit, Madrid, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Albillos, A:
Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Ctr Invest Biomed Red Area temat Enfermedades Hepa, Madrid, Spain
García, BP:
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Carbonell, SP:
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Sánchez, AM:
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Ganuza, M:
Hosp Univ Navarra, Navarrabiomed Biomed Res Ctr, Gastroenterol Dept, Pamplona, Spain
Reina, AIR:
Univ Complutense, Hosp Univ 12 Octubre, Res Inst I 12, Gastroenterol Dept, Madrid, Spain
Sanz, MD:
Hosp Rio Hortega, Dept Gastroenterol, Valladolid, Spain
De Frutos, D:
Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain
Garcia, JS:
Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain
Matallana, V:
Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain
Relea, L:
Univ Autonoma Madrid, Hosp Univ Puerta Hierro Majadahonda, Dept Digest Dis, IDIPHISA, Majadahonda, Madrid, Spain
Priego, LB:
Hosp del Mar Res Inst, Gastroenterol Dept, Barcelona, Spain
Muñiz, MP:
Hosp Cabuenes, Gastroenterol Dept, Gijon, Spain
Bellver, VO:
Hosp Univ & Politecn La Fe, Dept Gastroenterol & Hepatol, Gastrointestinal Endoscopy Unit, Inst Invest Sanitaria La Fe, Valencia, Spain
Lledó, JG:
Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid, Spain
Hernández, JA:
Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid, Spain
Segura, AM:
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Zamora, J:
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
Hosp Ramon & Cajal, Clin Biostat Unit, Madrid, Spain
Neves, JAC:
Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain
Algarve Univ Hosp Ctr, Dept Gastroenterol, Portimao, Portugal
Univ Algarve, Algarve Biomed Ctr, Faro, Portugal
Sequeiros, EV:
Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, M-607,Km 9,100 Fuencarral El Pardo, Madrid 28034, Spain
Inst Ramon y Cajal Invest Sanitaria IRYCIS, Liver & Digest Dis Res Grp, Madrid, Spain
|